Aldeyra Therapeutics Executes Lease for New Headquarters in Concord, MA

What Happened
Aldeyra Therapeutics, Inc. filed an 8-K (dated July 30, 2026) disclosing that on July 28, 2026 the company executed a lease agreement with Bradford Street, L.L.C. for approximately 4,067 square feet at 23 Bradford Street, Concord, Massachusetts. The Office Lease commences September 1, 2026 and runs through September 30, 2029, and Aldeyra intends to use the space as its corporate headquarters.

Key Details

• Premises: ~4,067 sq ft at 23 Bradford Street, Concord, MA.
• Lease term: begins Sept 1, 2026 and ends Sept 30, 2029.
• Base rent: $12,201.00 per month (scheduled to increase annually per the lease).
• Other obligations: tenant pays operating expenses, taxes and other fees; initial security deposit of $50,000.
• Counterparty: Bradford Street, L.L.C.; lease filed as Exhibit 10.1 to the 8-K.

Why It Matters
This filing reports a material lease agreement (Item 1.01) establishing Aldeyra’s planned corporate headquarters and fixed occupancy costs through 2029. For investors, the key takeaways are the location, committed space and known near-term cash obligations (monthly base rent and $50,000 deposit), which affect operating expenses and cash planning but do not directly report revenue or clinical progress. The full lease is included as an exhibit for details.